Total Debt Summary of CEL-SCI Corporation

CEL-SCI Corporation's latest annual total debt in 2023 was 13.57 Million USD , down -11.31% from previous year.
CEL-SCI Corporation's latest quarterly total debt in 2024 Q3 was 12.13 Million USD , down -3.95% from previous quarter.
CEL-SCI Corporation reported annual total debt of 15.3 Million USD in 2022, down -4.19% from previous year.
CEL-SCI Corporation reported annual total debt of 15.97 Million USD in 2021, up 14.6% from previous year.
CEL-SCI Corporation reported quarterly total debt of 12.63 Million USD for 2024 Q2, down -3.57% from previous quarter.
CEL-SCI Corporation reported quarterly total debt of 13.09 Million USD for 2024 Q1, down -3.48% from previous quarter.

Annual Total Debt Chart of CEL-SCI Corporation (2023 - 1989)

Historical Annual Total Debt of CEL-SCI Corporation (2023 - 1989)

Year	Total Debt	Total Debt Growth
2023	13.57 Million USD	-11.31%
2022	15.3 Million USD	-4.19%
2021	15.97 Million USD	14.6%
2020	13.93 Million USD	3.18%
2019	13.5 Million USD	0.96%
2018	13.37 Million USD	-5.82%
2017	14.2 Million USD	9.19%
2016	13.01 Million USD	934.09%
2015	1.25 Million USD	12.18%
2014	1.12 Million USD	-1.02%
2013	1.13 Million USD	3.02%
2012	1.1 Million USD	-78.0%
2011	4.99 Million USD	352.78%
2010	1.1 Million USD	-0.3%
2009	1.1 Million USD	453.67%
2008	200 Thousand USD	0.0%
2007	- USD	0.0%
2006	- USD	-100.0%
2005	3000.00 USD	0.0%
2004	- USD	-100.0%
2003	873.28 Thousand USD	-50.78%
2002	1.77 Million USD	5583.6%
2001	31.21 Thousand USD	25.77%
2000	24.82 Thousand USD	0.0%
1999	- USD	0.0%
1998	- USD	0.0%
1997	- USD	0.0%
1996	- USD	-100.0%
1995	800 Thousand USD	14.29%
1994	700 Thousand USD	0.0%
1993	- USD	0.0%
1992	- USD	0.0%
1991	- USD	0.0%
1990	- USD	0.0%
1989	- USD	-100.0%

Year	Total Debt	Total Debt Growth
2024 Q3	12.13 Million USD	-3.95%
2024 Q2	12.63 Million USD	-3.57%
2024 Q1	13.09 Million USD	-3.48%
2023 Q3	14.02 Million USD	-3.04%
2023 Q1	14.88 Million USD	-2.7%
2023 Q2	14.46 Million USD	-2.88%
2023 FY	13.57 Million USD	-11.31%
2023 Q4	13.57 Million USD	-3.2%
2022 Q1	15.62 Million USD	-2.17%
2022 Q4	15.3 Million USD	-2.49%
2022 Q3	15.69 Million USD	-2.18%
2022 Q2	16.04 Million USD	2.69%
2022 FY	15.3 Million USD	-4.19%
2021 Q4	15.97 Million USD	4.68%
2021 Q3	15.25 Million USD	15.09%
2021 Q2	13.25 Million USD	-3.19%
2021 Q1	13.69 Million USD	-1.74%
2021 FY	15.97 Million USD	14.6%
2020 Q3	14.15 Million USD	0.96%
2020 FY	13.93 Million USD	3.18%
2020 Q1	14.25 Million USD	5.51%
2020 Q2	14.02 Million USD	-1.62%
2020 Q4	13.93 Million USD	-1.55%
2019 Q2	13.44 Million USD	0.23%
2019 FY	13.5 Million USD	0.96%
2019 Q4	13.5 Million USD	0.24%
2019 Q3	13.47 Million USD	0.23%
2019 Q1	13.41 Million USD	0.26%
2018 Q1	14.13 Million USD	-0.54%
2018 FY	13.37 Million USD	-5.82%
2018 Q4	13.37 Million USD	0.32%
2018 Q3	13.33 Million USD	-7.84%
2018 Q2	14.47 Million USD	2.42%
2017 Q2	13.11 Million USD	0.38%
2017 FY	14.2 Million USD	9.19%
2017 Q4	14.2 Million USD	4260.48%
2017 Q3	325.79 Thousand USD	-97.51%
2017 Q1	13.06 Million USD	100276.6%
2016 FY	13.01 Million USD	934.09%
2016 Q1	1.11 Million USD	-11.71%
2016 Q2	4583.00 USD	-99.59%
2016 Q3	2309.00 USD	-49.62%
2016 Q4	13.01 Thousand USD	463.49%
2015 Q2	1.11 Million USD	-0.19%
2015 Q4	1.25 Million USD	-1.79%
2015 Q3	1.28 Million USD	14.66%
2015 Q1	1.11 Million USD	-0.19%
2015 FY	1.25 Million USD	12.18%
2014 Q1	1.13 Million USD	0.6%
2014 Q2	1.12 Million USD	-1.26%
2014 FY	1.12 Million USD	-1.02%
2014 Q4	1.12 Million USD	-0.18%
2014 Q3	1.12 Million USD	-0.18%
2013 Q1	1.13 Million USD	3.5%
2013 Q4	1.13 Million USD	-0.16%
2013 Q3	1.13 Million USD	-0.16%
2013 Q2	1.13 Million USD	-0.15%
2013 FY	1.13 Million USD	3.02%
2012 Q4	1.1 Million USD	0.0%
2012 Q2	1.1 Million USD	-62.77%
2012 Q1	2.95 Million USD	-40.89%
2012 FY	1.1 Million USD	-78.0%
2012 Q3	1.1 Million USD	0.0%
2011 FY	4.99 Million USD	352.78%
2011 Q4	4.99 Million USD	1.42%
2011 Q3	4.92 Million USD	346.44%
2011 Q2	1.1 Million USD	0.37%
2011 Q1	1.1 Million USD	-0.37%
2010 Q3	1.1 Million USD	0.0%
2010 Q4	1.1 Million USD	0.0%
2010 FY	1.1 Million USD	-0.3%
2010 Q2	1.1 Million USD	0.0%
2010 Q1	1.1 Million USD	-0.3%
2009 Q3	1.06 Million USD	85.96%
2009 Q1	100 Thousand USD	-50.0%
2009 Q2	570 Thousand USD	470.0%
2009 Q4	1.1 Million USD	4.47%
2009 FY	1.1 Million USD	453.67%
2008 Q1	- USD	0.0%
2008 Q2	656.34 Thousand USD	0.0%
2008 Q3	- USD	-100.0%
2008 Q4	200 Thousand USD	0.0%
2008 FY	200 Thousand USD	0.0%
2007 Q1	- USD	0.0%
2007 Q2	- USD	0.0%
2007 FY	- USD	0.0%
2007 Q4	- USD	0.0%
2007 Q3	- USD	0.0%
2006 FY	- USD	-100.0%
2006 Q2	3110.00 USD	141.46%
2006 Q4	- USD	0.0%
2006 Q3	- USD	-100.0%
2006 Q1	1288.00 USD	-57.07%
2005 Q2	- USD	0.0%
2005 Q4	3000.00 USD	0.0%
2005 FY	3000.00 USD	0.0%
2005 Q1	- USD	0.0%
2005 Q3	- USD	0.0%
2004 Q3	- USD	0.0%
2004 Q4	- USD	0.0%
2004 FY	- USD	-100.0%
2004 Q2	- USD	0.0%
2004 Q1	- USD	-100.0%
2003 Q2	1.06 Million USD	-3.49%
2003 Q1	1.1 Million USD	-37.86%
2003 FY	873.28 Thousand USD	-50.78%
2003 Q4	873.28 Thousand USD	-7.41%
2003 Q3	943.19 Thousand USD	-11.36%
2002 Q3	1.1 Million USD	-1.46%
2002 Q1	1 Million USD	3103.28%
2002 Q4	1.77 Million USD	61.08%
2002 Q2	1.11 Million USD	11.78%
2002 FY	1.77 Million USD	5583.6%
2001 Q1	24.82 Thousand USD	0.0%
2001 Q4	31.21 Thousand USD	0.0%
2001 Q3	- USD	-100.0%
2001 FY	31.21 Thousand USD	25.77%
2001 Q2	24.82 Thousand USD	0.0%
2000 Q4	24.82 Thousand USD	0.0%
2000 Q1	- USD	0.0%
2000 Q3	- USD	0.0%
2000 FY	24.82 Thousand USD	0.0%
2000 Q2	- USD	0.0%
1999 Q4	- USD	0.0%
1999 Q3	- USD	0.0%
1999 Q2	- USD	0.0%
1999 FY	- USD	0.0%
1999 Q1	- USD	0.0%
1998 FY	- USD	0.0%
1998 Q4	- USD	0.0%
1998 Q3	- USD	0.0%
1998 Q2	- USD	0.0%
1998 Q1	- USD	0.0%
1997 Q3	- USD	0.0%
1997 Q1	- USD	0.0%
1997 FY	- USD	0.0%
1997 Q4	- USD	0.0%
1997 Q2	- USD	0.0%
1996 FY	- USD	-100.0%
1996 Q2	600 Thousand USD	-14.29%
1996 Q3	1 Million USD	66.67%
1996 Q4	- USD	-100.0%
1996 Q1	700 Thousand USD	-12.5%
1995 FY	800 Thousand USD	14.29%
1995 Q3	800 Thousand USD	-11.11%
1995 Q1	700 Thousand USD	0.0%
1995 Q2	900 Thousand USD	28.57%
1995 Q4	800 Thousand USD	0.0%
1994 FY	700 Thousand USD	0.0%
1994 Q4	700 Thousand USD	0.0%
1994 Q3	- USD	0.0%
1994 Q2	- USD	0.0%
1994 Q1	- USD	0.0%
1993 Q3	- USD	0.0%
1993 Q4	- USD	0.0%
1993 FY	- USD	0.0%
1993 Q1	- USD	0.0%
1993 Q2	- USD	0.0%
1992 Q1	- USD	0.0%
1992 Q2	- USD	0.0%
1992 Q3	- USD	0.0%
1992 Q4	- USD	0.0%
1992 FY	- USD	0.0%
1991 FY	- USD	0.0%
1991 Q4	- USD	0.0%
1991 Q2	- USD	0.0%
1991 Q3	- USD	0.0%
1991 Q1	- USD	0.0%
1990 Q2	100 Thousand USD	0.0%
1990 Q4	- USD	0.0%
1990 FY	- USD	0.0%
1990 Q1	- USD	0.0%
1990 Q3	- USD	-100.0%
1989 Q3	200 Thousand USD	0.0%
1989 Q4	- USD	-100.0%
1989 FY	- USD	-100.0%
1989 Q1	200 Thousand USD	100.0%

Peer Total Debt Comparison of CEL-SCI Corporation

Name	Total Debt	Total Debt Difference
AIM ImmunoTech Inc.	495 Thousand USD	-2641.767%
Ampio Pharmaceuticals, Inc.	274 Thousand USD	-4853.193%
Armata Pharmaceuticals, Inc.	120.37 Million USD	88.725%
Actinium Pharmaceuticals, Inc.	2.11 Million USD	-542.298%
Azitra, Inc.	885.94 Thousand USD	-1431.892%
Can-Fite BioPharma Ltd.	39.99 Thousand USD	-33830.221%
Chromocell Therapeutics Corporation	1.26 Million USD	-969.749%
Calidi Biotherapeutics, Inc.	7.23 Million USD	-87.559%
iBio, Inc.	4.46 Million USD	-204.299%
Lineage Cell Therapeutics, Inc.	2.95 Million USD	-359.748%
MAIA Biotechnology, Inc.	- USD	-Infinity%
Matinas BioPharma Holdings, Inc.	3.55 Million USD	-281.658%
Navidea Biopharmaceuticals, Inc.	2.43 Million USD	-457.521%
NovaBay Pharmaceuticals, Inc.	2.74 Million USD	-395.319%
NanoViricides, Inc.	- USD	-Infinity%
Oragenics, Inc.	312.7 Thousand USD	-4240.14%
BiomX Inc.	15.09 Million USD	10.073%
BiomX Inc.	15.09 Million USD	10.073%
Protalix BioTherapeutics, Inc.	26.28 Million USD	48.359%
Palatin Technologies, Inc.	590.33 Thousand USD	-2198.979%
Scorpius Holdings, Inc.	14.04 Million USD	3.349%

Global Stocks Search

CEL-SCI Corporation (CVM)

Total Debt Summary of CEL-SCI Corporation

Annual Total Debt Chart of CEL-SCI Corporation (2023 - 1989)

Historical Annual Total Debt of CEL-SCI Corporation (2023 - 1989)

Peer Total Debt Comparison of CEL-SCI Corporation